Loading company…
PAM2L Biotechnologies develops protein and polysaccharide-based biomaterials.
Founded in 2021 and based in Shenzhen, China, PAM2L Biotechnologies uses synthetic biology and machine learning to develop protein and polysaccharide materials for pharmaceuticals, cosmetics, and food. It established a materials synthetic biology industry achievement transformation center with the Chinese Academy of Sciences in December 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in